Form 4 for WLTH WEALTHFRONT CORP
Accepted 2025-12-15 00:00:00 ET · period of report 2025-07-17 · accession 0001218470-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-15 | 2025-12-11 | WLTH | GOLDMAN KENNETH A | Dir | M - OptEx | $0.00 | +80.7K | 80.7K | New | $0 |
| DI | 2025-12-15 | 2025-12-15 | WLTH | GOLDMAN KENNETH A | Dir | C - Cnv Deriv | — | +53.7K | 48.4K | New | — |
| D | 2025-12-15 | 2025-12-11 | WLTH | GOLDMAN KENNETH A | Dir | S - Sale+OE | $14.00 | -38.1K | 42.6K | -47% | -$533.0K |
| DI | 2025-12-15 | 2025-12-11 | WLTH | GOLDMAN KENNETH A | Dir | S - Sale+OE | $14.00 | -5,373 | 0 | -100% | -$75.2K |
| DI | 2025-12-15 | 2025-07-17 | WLTH | GOLDMAN KENNETH A | Dir | G - Gift | — | -25.0K | 53.7K | -32% | — |
| DM | 2025-12-15 | 2025-12-11 | WLTH | GOLDMAN KENNETH A | Dir | M - OptEx | $0.00 | -80.7K | 0 | -100% | $0 |
| DI | 2025-12-15 | 2025-12-15 | WLTH | GOLDMAN KENNETH A | Dir | C - Cnv Deriv | — | -53.7K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | M | A | 6,945 | $0.00 | 6,945 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-11 | M | A | 27,778 | $0.00 | 34,723 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-11 | M | A | 30,500 | $0.00 | 65,223 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-15 | C | A | 53,732 | — | 48,359 | I By Goldman-Valeriote Family Trust | — | — | (F3) Pursuant to the Issuer's Restated Certificate of Incorporation, each share of Series C Convertible Preferred Stock ("Preferred Stock") may be converted, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering ("IPO") of its Common Stock, each share of Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-1. The securities have no expiration date. (F2) The reported securities are directly held by the Goldman-Valeriote Family Trust, for which the reporting person serves as trustee. |
| 5 | Common | Common Stock | 2025-12-11 | S | D | 38,071 | $14.00 | 42,648 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-11 | S | D | 5,373 | $14.00 | 0 | I By Goldman-Valeriote Family Trust | — | — | (F2) The reported securities are directly held by the Goldman-Valeriote Family Trust, for which the reporting person serves as trustee. |
| 7 | Common | Common Stock | 2025-12-11 | M | A | 15,496 | $0.00 | 80,719 | D | — | — | |
| 8 | Derivative | Series C Preferred Stock | 2025-07-17 | G | D | 25,000 | — | 53,732 | I By Goldman-Valeriote Family Trust | — · — to — | 25,000 Common Stock | (F4) The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the IPO, and the transaction is reported herein pursuant to Rule 16a-2(a). (F3) Pursuant to the Issuer's Restated Certificate of Incorporation, each share of Series C Convertible Preferred Stock ("Preferred Stock") may be converted, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering ("IPO") of its Common Stock, each share of Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-1. The securities have no expiration date. (F2) The reported securities are directly held by the Goldman-Valeriote Family Trust, for which the reporting person serves as trustee. |
| 9 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 6,945 | $0.00 | 0 | D | — · — to — | 6,945 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F7) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 10 | Derivative | Series C Preferred Stock | 2025-12-15 | C | D | 53,732 | — | 0 | I By Goldman-Valeriote Family Trust | — · — to — | 53,732 Common Stock | (F3) Pursuant to the Issuer's Restated Certificate of Incorporation, each share of Series C Convertible Preferred Stock ("Preferred Stock") may be converted, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering ("IPO") of its Common Stock, each share of Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-1. The securities have no expiration date. (F2) The reported securities are directly held by the Goldman-Valeriote Family Trust, for which the reporting person serves as trustee. |
| 11 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 30,500 | $0.00 | 0 | D | — · — to — | 30,500 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F10) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, January 25, 2023. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 12 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 15,496 | $0.00 | 0 | D | — · — to — | 15,496 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F11) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, February 21, 2024. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |
| 13 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 27,778 | $0.00 | 0 | D | — · — to — | 27,778 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F9) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, November 22, 2022. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |